c/glp1science · created 27 Oct 2023
Receptor pharmacology, mechanism, and the papers behind the headlines.
Splitting a weekly dose into two smaller injections comes up constantly so here's the actual PK argument, separated from the outcome-data question, which is a different…
Every week somebody asks whether Tuesday is better than Sunday, and every week the answer is buried under anecdote. Semaglutide's terminal half-life is roughly 168…
Genuinely asking, not being difficult. Everyone in c/tapering repeats that incretin is important. I believe it, but I have never seen anyone show why, and when I search…
Quick one. Canada here. gastric emptying works very differently where I live than in the threads that dominate the front page, and I keep seeing people confidently…
Reference standards, analytical reagents and system-suitability material. If you are running your own method, start with a known.
Reference standardsNot attacking anyone doing it, genuinely curious about the social/informational dynamic. There's essentially zero published outcome data for splitting or…
The mechanism layer: incretin physiology, receptor distribution, gastric emptying, central appetite signalling, glucagon-receptor contribution, amylin co-agonism, and the pharmacokinetics that make weekly dosing possible. Papers get cited by journal and year or they get a [needs source] reply.
Certified reference materials for peptide identity and purity work.
sigmaaldrich.comSeveral compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.
Reference